The US National Institutes of Health seeks to avoid the errors of the National Children's Study with its Precision Medicine Initiative.
Researchers update the estimation of how many bacterial cells are found in and on the human body.
In PLOS this week: sequencing of fecal samples gives clues to killer whales' diet, sporulation genes in Bacillus subtilis, and more.
George Church stopped by the Late Show with Stephen Colbert this week to talk about genome editing and de-extinction.
23andMe CEO Anne Wojcicki discusses genetic testing, including of children and prospective parents, with the Guardian.
A Nature editorial calls on researchers to expand their collaborative horizons.
In Science this week: sequencing finds Helicobacter pylori in a 5,300-year-old European glacial mummy, and more.
A study appearing in JAMA this week sparks debate on whether incidental genetic findings should be returned to patients.
Scientific societies and journals are starting to encourage researchers to sign up for and use a unique identifier.
FasterCures' Margaret Anderson says to keep a watch on personalized medicine and drug approvals this year.
In Nature this week: high-fidelity CRISPR/Cas9 nuclease, and more.
China is expected to announce its own precision medicine project, Nature News reports.
Through a long-term twin study, researchers estimate the heritability of cancer, as they report in JAMA.
In Genome Research this week: database of MRSA sequences, Arab populations split early from other non-African populations, and more.
While many people would want to help biomedical research, author Rebecca Skloot notes in an op-ed that they also want to give permission first.
Six years after an investigation found evidence of data fabrication, Nature has retracted a related article, Retraction Watch reports.
The Associated Press reports that the US Food and Drug Administration approved 45 new drugs last year.
In PNAS this week: genetic and proteomic study of the type VII secretion system in tuberculosis, miRNA expression differences in social and solitary locusts, and more.
A regulator's personal loss has influenced the speed of cancer drug approvals, the New York Times reports.
A new website called Depsy aims to track the influence of research software, Nature News reports.
Nobel laureate Shinya Yamanaka says his research focuses on helping patients, the Japan Times reports.
In PLOS this week: patterns in circulating tumor DNA and treatment response, genetic diversity in Colombian Plasmodium vivax, and more.
A patent examiner has issued an Initial Interference Memo in the CRISPR patent fight, possibly leading to an interference proceeding, according to the Law and Biosciences Blog.
University of Washington and Fred Hutchinson Cancer Research Center researchers examine factors influencing clinical cancer trials with low participant accrual rates.
The quiet of holiday breaks lends itself to getting research done, Stat News writes.